Literature DB >> 33176434

Prevalence of Cardiovascular Disorders in African-Americans With Congenital Prekallikrein Deficiency Versus Caucasians-Americans With the Same Defect.

Antonio Girolami1, Silvia Ferrari1, Bruno Girolami1.   

Abstract

Entities:  

Keywords:  bleeding; comorbities; deficiency; prekallikrein; thrombosis

Year:  2020        PMID: 33176434      PMCID: PMC7672757          DOI: 10.1177/1076029620972481

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


× No keyword cloud information.
Prekallikrein (PK) deficiency is a rare defect of the contact phase of blood coagulation.[1] Patients with this defect show no bleeding tendency. On the contrary, sporadic or preliminary studies indicate that they may present an increased incidence of atherosclerotic and thrombotic events.[2] The defect seems to concern mainly African-Americans who present a higher incidence of PK deficiency[3-5] as compared to Caucasian-Americans.[4] Since African-Americans (AA) suffer frequently of Cardiovascular Disorders (CVD), the role of PK deficiency could be maintained to act as a contributory causal effect.[6-8] Nevertheless, other environmental, nutritional and genetic factors may also be involved.[5] Sporadic reports of PK deficiency in other Africans have also appeared.[9,10] Unfortunately, no large clinical or genetic study is available. We thought it worth trying to correlate this high prevalence of PK deficiency seen in AA with CVD as compared with Caucasian-Americans with the same condition. AA with PK deficiency and CVD are gathered in Table 1.[11-24] It has to be noted that for a few papers dealing with PK defects, no ethnic background is indicated. It is likely that at least some of them may also involve AA. In the few instances we have succeeded in demonstrating it by direct or indirect contact with the Authors of the papers involved. Such cases are indicated with a) in Table 1.
Table 1.

African-Americans With PK Deficiency and Hypertension or Other CV Disorders.

Authors (year)Age/genderPK Activity (%)PK Antigen (%)Type of defectOther associated risk factorsCVDisordersComments; mutations available
Entes et al. (1981)M, 891.7n.r.HomOld ageCHF
Goodnough et al. (1983)a)
 Case 1M, 421AbsentHom.NoneIschemic StrokeFatal; Patient had also PE; The 3 cases were siblings
 Case 2F, 361AbsentSameObesityDVT
 Case 3F, 441AbsentSameObesityDVT;PE
Hess et al. (1991)F, 461n.r.HomNoneIschemic stroke
Pasricha et al. (1996)F, 281n.r.HomPregnancyNoneHypertension during a previous pregnancy; SC trait; Pregnancy;
Dasanu and Alexandrescu (2010)F, 7513n.r.HomOld ageNoneFrequent epistaxis probably due to hypertension,; Cys529Thr mutation
Bojanini et al. (2012)F, 321n.r.Prob.Hom.HypercolesterolemiaIschemic stroke
Quail (2013) a)
 Case 1F, 56LowN.r.Prob.Hom.NoneNoneHypertensive crisis
 Case 2M, 69LowN.r.Prob.Hom.NoneCAD, CABG
Oram et al. (2006)M, 751n.r.Hom.Old ageCAD, CABG
Cankovic et al. (2008) a)M, 57n.r.n.r.n.r.n.r.CAD, MI, CABGDiagnosis of HMWK not excluded
Baker et al. (2018)M, 15<5n.r.Prob.Hom.noneASD
Zhou et al. (2019) a)F, 50<5n.r.Hom.Arthritis athassiaHypertension
Dasgupta et al. (2020) a)M, 673AbsentHom.DiabetisHypertensionAngioedema after Lisinopril; Ser97Phe f.s. mutation
Yasin et al. (2020) a)M, 641n.r.Hom.Diabetis, ParkinsonSyncope,; Hypertension

M.I = Myocardial Infarction; CHF = congestive heart failure; CAD = coronary arterial disease; UA = unstable angina; CABG = coronary artery bypass graft; LMWH = low molecular weight heparin.f.s. = frame shift.

African-Americans With PK Deficiency and Hypertension or Other CV Disorders. M.I = Myocardial Infarction; CHF = congestive heart failure; CAD = coronary arterial disease; UA = unstable angina; CABG = coronary artery bypass graft; LMWH = low molecular weight heparin.f.s. = frame shift. There are at least 16 AA patients with PK deficiency and CVD. Since we do not know the total number of AA subjects with PK deficiency in the USA, we cannot draw general conclusions. On the basis of the available data, it would appear that about 50% of the reported AA patients with PK deficiency present CVDisordes.[4] On the contrary, the prevalence among Caucasians-Americans is only about 20%.[25-27] The incidence of CVD in Caucasian-Americans with PK deficiency is shown in Table 2. The difference is statistically significant (p = 0.01). This is based on the reported cases and therefore has limitations. Unfortunately, there is also no available study on the prevalence of PK deficiency in the Caucasian-American population.
Table 2.

Number of African-Americans (AA) With PK Deficiency and Cardiovascular Disorders (CVD) Versus Caucasian-Americans (CA) With PK Deficiency and CVD.

NumberPercentile Figure
African-Americans with PK Deficiency28/
African-Americans with PK Deficiency and CVD1657.1
Caucasian Americans with PK deficiency15/
Caucasian Americans with PK deficiency and CVD320.0

The difference is statistically significant (p < 0.01). The ethnic background of some patients was not stated in the original papers but it has been surmised or obtained on the basis of information gathered by the Authors of the present note.

Number of African-Americans (AA) With PK Deficiency and Cardiovascular Disorders (CVD) Versus Caucasian-Americans (CA) With PK Deficiency and CVD. The difference is statistically significant (p < 0.01). The ethnic background of some patients was not stated in the original papers but it has been surmised or obtained on the basis of information gathered by the Authors of the present note. The incidence of CVD seen in reported cases of AA with PK deficiency seems higher than that seen in the remaining population of the USA with PK deficiency (Table 2). It would seem that PK deficiency is more severe in AA as compared to Caucasian-Americans with the same defect. Alternatively, it could suggest that other predisposing causes favoring CVD are present in the AA population. This is intended only to indicate that PK deficiency may play a role in the genesis of these disorders and it does not exclude the role and/or the co-existence of other causes.
  25 in total

Review 1.  Congenital prekallikrein deficiency.

Authors:  Antonio Girolami; Pamela Scarparo; Nicole Candeo; Anna Maria Lombardi
Journal:  Expert Rev Hematol       Date:  2010-12       Impact factor: 2.929

2.  Fletcher factor deficiency in a woman requiring emergency caesarean section.

Authors:  M C Odumosu; W C Yoong; A F Fakokunde
Journal:  J Obstet Gynaecol       Date:  2009-07       Impact factor: 1.246

3.  Fletcher factor deficiency and myocardial infarction.

Authors:  Z Currimbhoy; V Vinciguerra; P Palakavongs; P Kuslansky; T J Degnan
Journal:  Am J Clin Pathol       Date:  1976-06       Impact factor: 2.493

4.  Fletcher factor deficiency in a 9-year-old girl: mechanisms of the contact pathway of blood coagulation.

Authors:  R A DeLa Cadena
Journal:  Am J Hematol       Date:  1995-04       Impact factor: 10.047

5.  Fletcher factor deficiency, source of variations of the activated partial thromboplastin time test.

Authors:  F M LaDuca; K D Tourbaf
Journal:  Am J Clin Pathol       Date:  1981-04       Impact factor: 2.493

6.  Prolonged activated partial thromboplastin time due to plasma prekallikrein deficiency: a case study and literature review on its clinical significance.

Authors:  Kehua Zhou; Diana Mehedint; Haider Khadim
Journal:  Blood Coagul Fibrinolysis       Date:  2019-09       Impact factor: 1.276

7.  A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage.

Authors:  Constantin A Dasanu; Doru T Alexandrescu
Journal:  Am J Med Sci       Date:  2009-11       Impact factor: 2.378

Review 8.  Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.

Authors:  L T Goodnough; H Saito; O D Ratnoff
Journal:  Medicine (Baltimore)       Date:  1983-07       Impact factor: 1.889

9.  Prolonged Activated Clotting Time Immediately Prior to Open Cardiac Surgery.

Authors:  Sarah M Baker; Ashley Kiefer; Dominic S Carollo; Rajasekharan P Warrier
Journal:  Ochsner J       Date:  2018

10.  Diagnostic Pearls and Clinical Implications of Prekallikrein Deficiency.

Authors:  Hassaan Yasin; Muhammad Omer Jamil; Lance A Williams Iii
Journal:  Cureus       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.